<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref046">
 <label>46</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Setthapramote</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Sasaki</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Puiprom</surname>
   <given-names>O</given-names>
  </name>, 
  <name>
   <surname>Limkittikul</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Pitaksajjakul</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Pipattanaboon</surname>
   <given-names>C</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection</article-title>. 
  <source>Biochem Biophys Res Commun</source>. 
  <year>2012</year>;
  <volume>423</volume>(
  <issue>4</issue>):
  <fpage>867</fpage>â€“
  <lpage>72</lpage>. Epub 2012/06/21. 
  <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.06.057</pub-id> .
  <?supplied-pmid 22713454?>
  <pub-id pub-id-type="pmid">22713454</pub-id>
 </mixed-citation>
</ref>
